Clinical Trials Browser

Phase 2 × OTHER_GOV × Non-Squamous Non-Small Cell Lung Cancer × Clear all

NCT06334757 2024-03-28

Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure

Phase 2 Unknown

Non-Squamous Non-Small Cell Lung Cancer